Labconco® and SKAN Collaborate to Set a New Standard in Sterility with the pure2 Aseptic Isolator
Contact
Adam Keithley | Vice President, Channel Management | Labconco
P R E S S R E L E A S E
KANSAS CITY, Missouri – Labconco® and SKAN Collaborate to Set a New Standard in Sterility with the pure2 Aseptic Isolator
Labconco Corporation announces its collaboration with SKAN, a global leader in aseptic isolator technology, to distribute the pure2 Aseptic Isolator in the North American market. Engineered to solve aseptic processing requirements for cell & gene therapy, sterility testing, pharmaceutical production and cytotoxic handling, the pure2 provides unparalleled protection while streamlining workflows in the most demanding environments.
“The pure2 sets a new benchmark for flexibility and performance in aseptic applications and accelerates Labconco’s long-standing commitment to safety of sterile products,” said Labconco’s Director of Biosafety Products David Wasescha. “With small batch advanced therapies continuing to grow in numbers, the pure2 lends a faster, safer and more flexible solution for preparation of these products.”
Maintaining sterility is a fundamental challenge in aseptic processing, where any level of contamination is unacceptable. The pure2 is designed to meet these challenges with GMP-compliant, ISO Grade A unidirectional airflow, a 21 CFR Part 11 compliant HMI, and unmatched construction quality. Built with premium materials and enhanced with SKAN’s skanfog® technology, the pure2 provides reliable H₂O₂ decontamination (hydrogen peroxide decon) cycles to safeguard batch-to-batch sterility.
“Beyond its technical strengths, the pure2 was designed with the user experience in mind,” said Labconco’s Product Manager Mike Zubelewicz. “Every feature – from its intuitive controls to its effortless glove integrity testing capabilities – aims to enhance safety, comfort and productivity.”
The pure2 is the answer for the unique demands of both research and GMP environments. Suitable for aseptic and aseptic-toxic processes, and customizable for various application needs, the pure2 bridges the gap for development and production of a diverse range of therapies.
For 100 years, Labconco has delivered innovative products designed to protect patients and the scientists behind new cures. The addition of the pure2 Isolator reflects this ongoing commitment to supporting the advancement of medicine through innovative engineering and unmatched performance.
The pure2 Aseptic Isolator is only available in the U.S., Canada, and Puerto Rico. For more information visit:
About Labconco
Since 1925, Labconco has partnered with scientists to create equipment that protect people, preserve discoveries, and expand the boundaries of innovation. Trusted worldwide, our biosafety cabinets, fume hoods, and freeze dryers have supported breakthroughs in medicine, forensics, and environmental science. As we honor our century of excellence, we’re driven to shape the next century of discovery. Science Forward – Together.
About SKAN
SKAN is a pioneer in the field of aseptic and aseptic-toxic manufacturing processes for the (bio-) pharmaceutical industry. The company is the market and technology leader for high-quality, process-critical isolator systems for filling drugs according to vigorous sterility standards. In addition, the company offers its customers process support, services and consumables. Innovative solutions and an efficient life-cycle support organisation make SKAN an important partner for the pharmaceutical and biotech industry, Contract Manufacturing Organisations (CMO’s) and research laboratories worldwide. Founded in 1968, SKAN employs 1469 people as of the reporting year. More than half of them work at the Allschwil headquarters in the Life Sciences Hub of the Basel region. The other employees are spread between the subsidiaries in Switzerland, Germany, Belgium, Japan and the USA.